Abbott, AbbVie Hit With $2.2M Verdict In Humira Suit

Law360, New York (May 9, 2013, 7:28 PM EDT) -- A Chicago jury slapped Abbott Laboratories and AbbVie Inc. with a $2.2 million verdict Thursday in a suit brought by a man whose wife allegedly suffered a life-threatening fungal infection as a result of taking the blockbuster arthritis drug Humira.

The state court jury found for plaintiff Milton Tietz on his negligence claim, though it found for the companies on a product defect claim, according to Jim Perdue Jr. of Perdue Kidd & Vickery, an attorney for Tietz. Abbott spun off AbbVie earlier this year....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.